Fidelity variants of RNA dependent RNA polymerases uncover an indirect, mutagenic activity of amiloride compounds

Autor: Laura I. Levi, Malia J. McPherson, Jamie J. Arnold, Stéphanie Beaucourt, Bruno Baron, Marco Vignuzzi, Nina F. Gnädig
Přispěvatelé: Populations virales et Pathogenèse, Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS), Biophysique des Macromolécules et de leurs Interactions, Department of Biochemistry and Molecular Biology, Pennsylvania State University (Penn State), Penn State System-Penn State System, ANR-09-JCJC-0118,QuasispeciesVax(2009), Institut Pasteur [Paris]-Centre National de la Recherche Scientifique (CNRS)
Jazyk: angličtina
Rok vydání: 2010
Předmět:
Transcription
Genetic

viruses
MESH: Base Sequence
medicine.disease_cause
MESH: Amiloride
Amiloride
Chlorocebus aethiops
MESH: Animals
MESH: Genetic Variation
Mutation frequency
lcsh:QH301-705.5
Polymerase
Enterovirus
MESH: Mutagenesis
0303 health sciences
Mutation
biology
MESH: Enterovirus
DNA-Directed RNA Polymerases
3. Good health
MESH: RNA
Viral

[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
RNA
Viral

Research Article
medicine.drug
lcsh:Immunologic diseases. Allergy
MESH: Antiviral Agents
Immunology
RNA-dependent RNA polymerase
MESH: Vero Cells
Antiviral Agents
Microbiology
03 medical and health sciences
MESH: RNA
Virology
MESH: Mutagens
Genetics
medicine
Animals
Humans
Vero Cells
Molecular Biology
MESH: Templates
Genetic

030304 developmental biology
Virology/Antivirals
including Modes of Action and Resistance

MESH: Humans
Base Sequence
030306 microbiology
MESH: Transcription
Genetic

Mutagenesis
Genetic Variation
RNA
Templates
Genetic

Virology/Mechanisms of Resistance and Susceptibility
including Host Genetics

Molecular biology
MESH: Cercopithecus aethiops
Virology/New Therapies
including Antivirals and Immunotherapy

MESH: DNA-Directed RNA Polymerases
MESH: Hela Cells
lcsh:Biology (General)
Viral replication
biology.protein
Parasitology
lcsh:RC581-607
HeLa Cells
Mutagens
Zdroj: PLoS Pathogens
PLoS Pathogens, 2010, 6 (10), pp.e1001163. ⟨10.1371/journal.ppat.1001163⟩
PLoS Pathogens, Public Library of Science, 2010, 6 (10), pp.e1001163. ⟨10.1371/journal.ppat.1001163⟩
PLoS Pathogens, Vol 6, Iss 10, p e1001163 (2010)
ISSN: 1553-7366
1553-7374
DOI: 10.1371/journal.ppat.1001163
Popis: In a screen for RNA mutagen resistance, we isolated a high fidelity RNA dependent RNA polymerase (RdRp) variant of Coxsackie virus B3 (CVB3). Curiously, this variant A372V is also resistant to amiloride. We hypothesize that amiloride has a previously undescribed mutagenic activity. Indeed, amiloride compounds increase the mutation frequencies of CVB3 and poliovirus and high fidelity variants of both viruses are more resistant to this effect. We hypothesize that this mutagenic activity is mediated through alterations in intracellular ions such as Mg2+ and Mn2+, which in turn increase virus mutation frequency by affecting RdRp fidelity. Furthermore, we show that another amiloride-resistant RdRp variant, S299T, is completely resistant to this mutagenic activity and unaffected by changes in ion concentrations. We show that RdRp variants resist the mutagenic activity of amiloride via two different mechanisms: 1) increased fidelity that generates virus populations presenting lower basal mutation frequencies or 2) resisting changes in divalent cation concentrations that affect polymerase fidelity. Our results uncover a new antiviral approach based on mutagenesis.
Author Summary RNA viruses have extreme mutation frequencies, due in large part to the erroneous nature of the viral RNA dependent RNA polymerases (RdRp) that replicate their genomes. Since RdRp lack proofreading and repair mechanisms, the use of base analogs as RNA mutagens to increase lethal mutations and extinguish the virus population is a promising antiviral strategy. Recently, a screen for resistance to this antiviral treatment identified a higher fidelity RdRp variant of poliovirus, indicating that RdRp fidelity can be modulated by single amino acid substitutions. To extend these observations to other viruses, we performed a similar screen using Coxsackie virus B3 (CVB3). We identified a new high fidelity RdRp variant which was also resistant to amiloride compounds that have no known mutagenic activity. Using wild type and RdRp fidelity variants of poliovirus and CVB3, we show that amiloride compounds do have mutagenic activity and act on RNA virus populations indirectly, by altering intracellular ion concentrations that affect polymerase fidelity. Our results identify a new means of targeting viruses through increases in mutation frequency using non-nucleoside compounds that alter the cellular environment in which the virus replicates.
Databáze: OpenAIRE